Point72 Asset Management »

Enliven Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21M 1.0M 20.47
2025-06-30 $27M 1.4M 20.06
2025-03-31 $2.8M 140k 19.68
2023-03-31 $16k 746 21.90

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Fairmount Funds Management
BlackRock
VR Adviser
Polar Capital Holdings
Vanguard Group
Henderson Group
Novo A/S
Pictet Asset Management Holding SA
Blackstone Group
Capital Research Global Investors
Citadel Advisors
Vestal Point Capital

View all funds holding Enliven Therapeutics